5 News & Press Releases found
StemBioSys, Inc. News
-
StemBioSys Closes $6.6 Million Series C Financing
Privately-held StemBioSys, Inc., based in San Antonio, announced today that it had closed on an oversubscribed $6.6 million Series C Preferred Stock financing in August. According to StemBioSys CEO Bob Hutchens, the company is investing the proceeds ...
-
Dr. Jeanne Loring Joins StemBioSys Scientific Advisory Board; World-renowned leader in Stem Cell Biology
Dr. Jeanne Loring, Professor Emeritus of The Scripps Research Institute, Founding Director of the Center for Regenerative Medicine at Scripps, and founder of Aspen Neuroscience, has joined the Scientific Advisory Board of StemBioSys, Inc., (SBS) a ...
-
StemBioSys participates in Biotech Showcase Digital during J.P. Morgan Week 2021
StemBioSys, Inc., a privately held biomedical company that manufactures and develops innovative, advanced human stem cell technologies to improve the predictive power of pre-clinical drug safety screening, today announced its President and ...
-
StemBioSys and Cartox Announce Publication of Research Demonstrating CELLvo™ Matrix Plus Significantly Enhances the Functionality of hiPSC Cardiomyocytes
StemBioSys, Inc. (StemBioSys) and CarTox, Inc. (Cartox) announced today the publication of research in Nature Scientific Reports demonstrating that CELLvo™ Matrix Plus, an extracellular matrix (ECM) technology derived from human perinatal stem ...
-
StemBioSys expands its human chondrocyte offerings
StemBioSys introduced a new culture system designed to help investigators grow human chondrocytes in vitro faster while retaining a natural phenotype. The kit is comprised of CELLvo™ Matrix, a cell-derived extracellular matrix that mimics the ...